Long-term safety of in utero exposure to anti-TNF alpha drugs for the treatment of inflammatory bowel diseases (IBD): Interim results of the TEDDY study

Chaparro M;Magro F;Savarino E;Zabana Y;Pugliese D;Shitrit ABG;Samue LF;Lopez-Serrano P;Casanova MJ;Fernandez-Salazar L;Gutierrez A;Vicente R;Gravito-Soares E;Rodriguez C;Sebkova L;Lissner D;Magarotto A;Rodriguez-Lago I;Huguet JM;Palomares MTDL;Fiorino G;Guerra I;Mantzaris GJ;Silva M;Bartolo O;Donday MG;Ramas M;de Carpi JM;Gisbert JP

2016-01-01